ARRY-438162
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ARRY-438162, covering 2016-11-07 to 2016-11-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ARRY-438162 in Patients With Rheumatoid Arthritis [Phase 2]